XianLingGuBao protects against osteoporosis through activating STAT3 in vitro and vivo

• Main Authors: Zhihua Li (Author), Yongsheng Liu (Author), Li Ren (Author), Yang Sun (Author), Xin Guo (Author), Leiqi Ren (Author), Shancheng Guo (Author), Yuhua Li (Author), Yinbo Niu (Author)
• Format: Book
• Published: Elsevier, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: XianLingGuBao (XLGB) is a potent traditional Chinese patent medicine used to treat osteoporosis (OP), osteoarthritis, aseptic bone necrosis, and other musculoskeletal disorders. The current study aims to identify the active ingredients of XLGB and further elucidate its mechanism on OP tr...